Victoria Reade has 25 years, broad management experience within the intersection of healthcare, technology, and biotechnology. She has held senior leadership positions in start-up and mature,
Fortune 500 companies within Payer/Health Plan, Managed Care, Physician Group, Hospital and Biotech companies. Presently, Ms. Reade is a Management Consultant assisting early stage, life
sciences companies with securing funding, proof of concept, and commercializing their product and business model. She was formerly, the President & CEO of iontherapeutics, an early stage, medical device and cell therapeutics company developing novel solutions for broad application in orphan diseases, ophthalmology, and other disease states. Ms. Reade led a global, multi-disciplinary, clinical, research, manufacturing, and regulatory team in achieving significant milestones including securing a FDA 510k device exemption. She also served as Research Team Leader for a pre-clinical, research study comprised of cross-functional team from Harvard/ Schepens Eye Institute and University of California San Diego (UCSD). In her management roles within the healthcare industry, Ms. Reade spearheaded complex Operations, Clinical (UM/QI), Change Management, IT, Contracting, Strategic Partnerships, and Patient-centric initiatives focused on patient access, quality of care, and patient satisfaction.
Ms. Reade has a Bachelor of Science in Nursing (BSN) from the University of Tennessee Memphis Center for Health Sciences and an MBA from Pace University.